Prevalence of cough during angiotensin-converting enzyme inhibitor therapy.
Goldszer
R C
RC
Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Lilly
L S
LS
Solomon
H S
HS
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D002216:Captopril / Q000009:adverse effects; D017315:Cilazapril; D003371:Cough / Q000139:chemically induced*; D004656:Enalapril / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D010614:Pharynx / Q000187:drug effects; D011724:Pyridazines / Q000009:adverse effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D011724:Pyridazines; D017315:Cilazapril; D004656:Enalapril; D002216:Captopril